Nok Therapeutics, Inc.

Overview

Compare with another stock.

• TickerNKTPD on OTC¹
• IndustryPharmaceutical Preparations¹
• HeadquartersCranberry Twp, Pennsylvania¹
• Incorporated inFL²
• Business address2009 Mackenzie Way, Ste 100, Cranberry Twp, Pa 16066²
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive Officer, DirectorBrian Cogley named Apr 22, 2026 to May 1, 2026³
• No family relationship with Martin Lewis or Michael LewisRobert Lewis named Apr 22, 2026 to May 1, 2026³
• DirectorBruce Cassidy named Apr 22, 2026 to May 1, 2026³
• No family relationship with Michael Lewis or Robert LewisMartin Lewis named Apr 22, 2026 to May 1, 2026³
• PromoterDavid Mehalick named Apr 22, 2026 to May 1, 2026³
• No family relationship with Martin Lewis or Robert LewisMichael Lewis named Apr 22, 2026 to May 1, 2026³

Filings

34 filings to the SEC since October 2021: 8 private raises, 26 other. The latest 20:

1. Sep 28, 20261-SA SEMIANNUAL REPORT PURSUANT TO REGULATION A EDGAR
2. Jul 15, 20261-U CURRENT REPORT EDGAR
3. Jun 3, 20261-U CURRENT REPORT EDGAR
4. May 1, 2026D/A EDGAR
5. May 1, 2026D/A EDGAR
6. Apr 30, 20261-K EDGAR
7. Apr 22, 2026D/A EDGAR
8. Apr 22, 2026D/A EDGAR
9. Apr 22, 2026D/A EDGAR
10. Mar 26, 2026D EDGAR
11. Oct 24, 2025D EDGAR
12. Oct 24, 2025D EDGAR
13. Sep 30, 20251-SA SEMIANNUAL REPORT PURSUANT TO REGULATION A EDGAR
14. May 6, 20251-K EDGAR
15. Jan 3, 2025QUALIF EDGAR
16. Dec 30, 2024CORRESP EDGAR
17. Dec 23, 2024CORRESP EDGAR
18. Dec 23, 20241-A/A EDGAR
19. Dec 20, 2024UPLOAD EDGAR
20. Dec 17, 2024CORRESP EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Sep 24, 2024Raised $750,500 in a private offering of equity⁴ Form D: 5 investors so far Form D
2. Aug 6, 2024Raised $649,000 in a private offering of equity⁵ Form D: $750,000 offered in all Form D
3. Jun 11, 2024Raised $3,200 in a private offering of equity³ Form D: 14 investors so far Form D

SEC filer profile

How Nok Therapeutics, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARNok Therapeutics, Inc.¹
• CIK0002038166
• Employer ID (EIN)99-3344253¹
• Incorporated inFlorida¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address2009 Mackenzie Way, Ste 100, Cranberry Twp, PA 16066¹
• Phone888-691-5839¹
• On EDGAR sinceSep 26, 2024¹
• Filings34 in all: CORRESP (7), 1-A/A (6), D/A (5), UPLOAD (5), D (3), 1-K (2), 1-SA (2), 1-U (2)¹
  All 10 form types

  1-A (1), QUALIF (1)